Table 4.
Prevalence and control of risk factors in adults 40 or older with peripheral arterial disease (PAD) or coronary heart disease (CHD) *, NHANES 1999 - 2004
| Total PAD N =595 |
Total CHD N = 845 |
PAD (ABI <0.90) without a history of CHD N = 448 |
CHD without PAD (ABI <0.90) N = 698 |
P-value‡ | |
|---|---|---|---|---|---|
| Hypertension, % (SE) | 70.9 (2.2) | 67.7 (2.1) | 67.7 (2.4) | 65.5 (2.3) | 0.56 |
| Aware, % (SE) | 82.4 (1.8) | 89.5 (1.4) | 80.1 (22) | 89.8 (1.6) | 0.002 |
| Treated, % (SE) | 70.2 (2.8) | 83.6 (1.4) | 66.2 (3.2) | 84.3 (1.7) | <0.001 |
| Controlled, % (SE) | 48.0 (3.5) | 58.5 (3.0) | 46.6 (3.7) | 60.1 (2.9) | 0.004 |
| High total cholesterol (≥240 mg/dl) , % (SE) | 48.1 (2.6) | 57.7 (1.8) | 42.2 (2.7) | 56.4 (1.8) | <0.001 |
| Aware, % (SE) | 84.2 (2.5) | 91.7 (1.8) | 81.3 (3.2) | 92.1 (1.8) | 0.006 |
| Treated, % (SE) | 62.3 (3.7) | 79.6 (2.6) | 53.0 (4.5) | 79.5 (3.1) | <0.001 |
| Controlled, % (SE) | 82.0 (3.5) | 83.6 (2.2) | 82.2 (3.9) | 83.9 (2.0) | 0.70 |
| Diagnosed diabetes, % | 20.0 (2.5) | 20.6 (1.6) | 17.1 (2.5) | 19.2 (2.0) | 0.54 |
| No medication use, % (SE) | 11.1 (4.2)‡ | 15.6 (3.8) | 15.2 (6.0)‡ | 18.7 (4.5) | 0.64 |
| Insulin only, % (SE) | 22.3 (5.5) | 16.2(3.6) | 10.6 (3.7) | 9.3 (2.2) | 0.74 |
| Oral medications only, % (SE) | 54.8 (6.4) | 53.9 (4.5) | 57.3 (6.8) | 54.8 (5.2) | 0.76 |
| Both insulin and oral medications, % (SE) | 11.9 (2.5) | 14.3 (3.6) | 16.9 (4.1) | 17.2 (4.4) | 0.94 |
| Mean hemoglobin A1c , %-point (SE) | 7.4 (0.2) | 7.1 (0.1) | 7.5 (0.3) | 7.0 (0.1) | 0.19 |
| Smoking, % (SE) | |||||
| Current | 24.8 1.7) | 18.9 (1.7) | 24.7 (2.0) | 17.8 (1.9) | 0.006 |
| Former | 40.9 (2.7) | 46.0 (1.9) | 36.6 (3.2) | 44.6 (2.0) | 0.04 |
| Peripheral arterial disease (ABI <0.9), % (SE) | - | 14.8 (1.7) | - | - | - |
| History of coronary heart disease, % (SE) | 25.5 (2.5) | - | - | - | - |
| History of stroke, % (SE) | 10.4 (1.4) | 12.1 (1.5) | 7.2 (1.3) | 10.7 (1.5) | 0.12 |
| Daily aspirin Use, % (SE)§ | 63.8 (5.9) | 74.3 (2.7) | 59.0 (7.8) | 74.3 (3.1) | 0.07 |
| Mean Framingham Risk Score, points (SE) | 14.8 (0.7) | 14.0 (0.6) | 13.7 (0.8) | 13.3 (0.6) | 0.63 |
| Framingham Risk Score | |||||
| < 10% | 31.6 (3.4) | 32.3 (3.2) | 35.8 (3.6) | 34.5 (3.2) | 0.79 |
| 10-20% | 42.3 (3.8) | 45.5 (2.6) | 42.3 (3.8) | 46.0 (2.6) | 0.48 |
| >20% | 26.1 (3.3) | 22.2 (2.5) | 21.8 (3.3) | 19.5 (2.4) | 0.51 |
*
Analyses limited to those persons non-missing information on cardiovascular risk factor and treatment information (N=7,100).
†
P-values for comparison of the PAD without a history of CHD group to the CHD without a history of PAD group.
‡
Relative standard error is >30%. Estimate may be unreliable.
§
At the time of submission, data on aspirin use was not available for NHANES 2003-2004 The analysis of aspirin use is based on data from NHANES 1999-2002 only (N= 1,410)